Caroline Astbury
Overview
Explore the profile of Caroline Astbury including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
803
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vanderscheldon R, Sukov W, Gardner J, Rehder C, Levy B, Velagaleti G, et al.
Genes (Basel)
. 2025 Jan;
15(12.
PMID: 39766879
The joint College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee works to ensure the competency and proficiency of clinical cytogenetic testing laboratories through proficiency testing (PT)...
2.
Agrawal S, Ameline B, Folpe A, Azzato E, Astbury C, Mentzel T, et al.
Histopathology
. 2024 Jun;
85(4):649-659.
PMID: 38867577
Aims: The majority of dermatofibrosarcoma protuberans (DFSP) harbour PDGFB or PDGFD rearrangements. We encountered ALK expression/rearrangement in a PDGFB/D-negative CD34-positive spindle cell neoplasm with features similar to DFSP, prompting evaluation...
3.
Boles B, Gardner J, Rehder C, Levy B, Velagaleti G, Toydemir R, et al.
Arch Pathol Lab Med
. 2024 Jun;
149(3):211-216.
PMID: 38838342
Context.—: The joint College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee works to ensure competency and proficiency of clinical cytogenetics testing laboratories through proficiency testing programs...
4.
Schuetze S, Ballman K, Heise R, Ganjoo K, Davis E, George S, et al.
Clin Cancer Res
. 2024 Mar;
30(20):4584-4592.
PMID: 38446990
Purpose: Epithelioid hemangioendothelioma (EHE) is a rare vascular cancer with pathogenic TAZ-CAMTA1 (calmodulinbinding transcription activator 1) operating as an oncogenic driver through activation of the MAPK pathway. Trametinib is an...
5.
Fritchie K, Dermawan J, Astbury C, Sharma A, Bakhshwin A, Fuller L, et al.
Virchows Arch
. 2023 Jul;
483(2):237-243.
PMID: 37468653
Microcystic/reticular schwannoma (MRS) is a benign variant of schwannoma with a predilection for the gastrointestinal tract and skin. To date, genetic characterization of this tumor is limited. Prompted by the...
6.
Joehlin-Price A, Komforti M, Ladwig N, Devine P, Hoyle C, McCoy L, et al.
Am J Surg Pathol
. 2023 Mar;
47(5):580-588.
PMID: 36939053
Among gynecologic cancers, uterine serous carcinoma (USC) has been shown to be human epidermal growth factor receptor 2 (HER2) amplified and trastuzumab has been included in the recent National Comprehensive...
7.
Raca G, Astbury C, Behlmann A, De Castro M, Hickey S, Karaca E, et al.
Genet Med
. 2022 Dec;
25(2):100316.
PMID: 36507974
No abstract available.
8.
McAfee J, Scarborough R, Jia X, Azzato E, Astbury C, Ronen S, et al.
J Cutan Pathol
. 2022 Oct;
50(2):155-168.
PMID: 36261329
Background: Spitzoid melanocytic neoplasms are diagnostically challenging; criteria for malignancy continue to evolve. The ability to predict chromosomal abnormalities with immunohistochemistry (IHC) could help select cases requiring chromosomal evaluation. Methods:...
9.
10.
Astbury C, Benkendorf J
Genet Med
. 2022 Mar;
24(1):253-253.e1.
PMID: 35318940
This document was retired by the American College of Medical Genetics and Genomics (ACMG) Board of Directors as of May 20, 2019 with the following addendum.